Is IL2RG oncogenic in T-cell development?
K Pike-Overzet (External organisation)
D De Ridder (TU Delft - Multimedia Computing)
F Weerkamp (External organisation)
MRM Baert (External organisation)
MM Verstegen (External organisation)
MH Brugman (External organisation)
SJ Howes (External organisation)
Marcel Reinders (TU Delft - Multimedia Computing)
AJ Thrashers (External organisation)
G Wagemaker (External organisation)
JJM van Dongen (External organisation)
FJT Staal (External organisation)
More Info
expand_more
Abstract
The gene IL2RG encodes the -chain of the interleukin-2 receptor and is mutated in patients with X-linked severe combined immune deficiency (X-SCID). Woods et al.1 report the development of thymus tumours in a mouse model of X-SCID after correction by lentiviral overexpression of IL2RG and claim that these were caused by IL2RG itself. Here we find that retroviral overexpression of IL2RG in human CD34+ cells has no effect on T-cell development, whereas overexpression of the T-cell acute lymphoblastic leukaemia (T-ALL) oncogene LMO2 leads to severe abnormalities. Retroviral expression of IL2RG may therefore not be directly oncogenic ¿ rather, the restoration of normal signalling by the interleukin-7 receptor to X-SCID precursor cells allows progression of T-cell development to stages that are permissive for the pro-leukaemic effects of ectopic LMO2.
No files available
Metadata only record. There are no files for this record.